![]() |
|
|
Vol. 25, Issue 12, 1442-1446, 1997
Faculty of Pharmaceutical Sciences (T.S., K.T., H.Y., K.O.)
and
Faculty of Medicine (T.I.), Kyushu University
To study the specific target to which phenobarbital (PB) binds,
resulting in the induction of cytochrome P450, we prepared two
azido-PBs (AZPBs) as photoaffinity ligands. The azido substituent was
introduced at the para- or meta-position of the
PB aromatic ring. In this study, we estimated the utility of these
compounds by examining their inducing activities in vivo in
rats. Induction was assessed by immunoblotting with anti-CYP2B1/2
antibody and measuring testosterone-metabolizing activity, using
hepatic microsomes. Administration of p-AZPB to rats
increased hepatic CYP2B1/2 protein and testosterone 16
-hydroxylase
activity, although the effects were less than those of unmodified PB.
m-AZPB showed no effect in the induction of CYP2B1/2. To
assess the specificity of the effects of substituents, we compared the
inducing activities of p/m-nitro-PBs,
p/m-amino-PBs, and
p/m-hydroxy-PBs with those of AZPBs. The
results showed that p-nitro-PB, m-amino-PB, and
p-hydroxy-PB were also potent inducers for CYP2B1/2, with
lower activity than that of unmodified PB, whereas the other three
isomers had no effect. These results suggest that 1) the absence of any
substituents on the aromatic ring of PB is needed for maximal inducing
activity and 2) substitution at the meta-position of the PB
aromatic ring tends to reduce effectiveness as an inducer more than
does substitution at the para-position. Because
p-amino-PB and p-acetylamino-PB, the minor and
major metabolites of p-AZPB, respectively, were without
effect in the induction of CYP2B1/2, the effect of p-AZPB was considered to be due to the unchanged compound itself. The present
study demonstrates that, based on the weak but positive ability to
induce CYP2B1/2, p-AZPB may be a useful tool for
identifying the putative PB receptor.
This article has been cited by other articles:
![]() |
H. Yamada, H. Matsunaga, K. Tsuji, S. Matsumoto, M. Yamamoto, Y. Ishii, C. J. Omiecinski, and K. Oguri Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2 J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 986 - 993. [Abstract] [Full Text] |
||||
![]() |
H. Yamada, Y. Matsuki, T. Yamaguchi, and K. Oguri Effect of a Ligand Selective for Peripheral Benzodiazepine Receptors on the Expression of Rat Hepatic P-450 Cytochromes: Assessment of the Effect In Vivo and in a Hepatocyte Culture System Drug Metab. Dispos., November 1, 1999; 27(11): 1242 - 1247. [Abstract] [Full Text] |
||||